首页 | 本学科首页   官方微博 | 高级检索  
     


Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial
Authors:Priyathama Vellanki MD  Neda Rasouli MD  David Baldwin MD  Sara Alexanian MD  Isabel Anzola MD  Maria Urrutia MD  Saumeth Cardona MD  Limin Peng PhD  Francisco J. Pasquel MD  Guillermo E. Umpierrez MD  Linagliptin Inpatient Research Group
Affiliation:1. Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia;2. Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado-Denver, Denver, Colorado;3. Division of Endocrinology, Department of Medicine, Rush University Medical Center, Chicago, Illinois;4. Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, Boston University, Boston, Massachusetts;5. Department of Biostatistics, Rollins School of Public Health, Emory University, Atlanta, Georgia
Abstract:
Keywords:DPP-IV inhibitor  glycaemic control  incretin therapy  randomised trial
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号